semaglutide digestive blockage lawsuit in louisiana dallas gi obstruction law office gastric intestinal firm semaglutide attorney louisiana semaglutide obstruction lawyer in louisiana Louisiana Diabetes Drugs & Gastrointestinal Injuries-mvanhaasteren.nl semaglutide digestive blockage law office

This occurs when blood is digested as it passes through the intestinal tract, resulting in the characteristic dark appearance

(FDA approvals of Wegovy for cardiovascular disease and Zepbound for sleep apnea occurred in 2024 and therefore these uses are likely not reflected in Part D data through 2024.) More than half of gross spending in 2024 was on semaglutide products (Ozempic, 47%

Sema, semaglutide

The Food and Drug Administration (FDA) has approved both drugs for weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Wegovy also has the following approved uses: Cardiovascular health: Wegovy is approved to reduce the risk of major heart-related events like heart attack or stroke in adults with known heart disease who have obesity or are overweight